Charles River Laboratories International, Inc.CRLNYSE
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P14
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-0.85%
2024-1.92%
20233.86%
202212.31%
202121.08%
202011.55%
201915.67%
201821.99%
201710.48%
201623.34%